Skye Bioscience Inc (SKYE): PATENT CITATIONS Cited Patent Filing da...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Skye Bioscience Inc (SKYE)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	607
Boards Moderated	0
Alias Born	06/07/2010

Re: None

Wednesday, 03/08/2017 5:45:49 PM

Wednesday, March 08, 2017 5:45:49 PM

PATENT CITATIONS
Cited Patent Filing date Publication date Applicant Title
US5389375 * May 21, 1993 Feb 14, 1995 University Of Mississippi Stable suppository formulations effecting bioavailability of ?9 -thc
US6008383 * Oct 26, 1998 Dec 28, 1999 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
$NMUS Drug- NB1222 is a homerun with suppository delivery. Long time in the making, first patent filed in 2009 for formulation.
https://www.google.com/patents/US20110275555

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SKYE News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/20/2024 04:15:09 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:27:44 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM

More SKYE News

InvestorsHub NewsWire

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow